Esperion Therapeutics, Inc.: Hypercholesterolemia trials
The registry lists 13 Hypercholesterolemia studies with Esperion Therapeutics, Inc. as lead sponsor. 0 are open to participants now and 10 have results posted.
Phase 2 8Phase 3 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)CompletedNCT05694260Phase 2Results posted
- Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor TherapyCompletedNCT03193047Phase 2Results posted
- Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)CompletedNCT03067441Phase 3Results posted
- Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-CCompletedNCT03051100Phase 2Results posted
- Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)CompletedNCT03001076Phase 3Results posted
- Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular RiskCompletedNCT02991118Phase 3Results posted
- Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin IntolerantCompletedNCT02988115Phase 3Results posted
- Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)CompletedNCT02666664Phase 3Results posted
- Evaluation of ETC-1002 in Participants With Hypercholesterolemia and HypertensionCompletedNCT02178098Phase 2Results posted
- A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin IntoleranceCompletedNCT01751984Phase 2Results posted
- Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin TherapyCompletedNCT02072161Phase 2
- Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic PatientsCompletedNCT01941836Phase 2
- A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With HypercholesterolemiaCompletedNCT01779453Phase 2